Statements (21)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:chemical_compound
|
| gptkbp:CASNumber |
280744-09-4
|
| gptkbp:effect |
inhibits GSK-3 activity
|
| gptkbp:function |
GSK-3 inhibitor
|
| gptkbp:hasInChIKey |
QZQJXGZKZQZQJX-UHFFFAOYSA-N
|
| gptkbp:hasMolecularFormula |
C18H15N5O2S2
|
| gptkbp:hasSMILES |
CN1C=NC(=C1)C2=CC(=O)NC(=O)C2C3=C(C=C(C=C3)Cl)Cl
|
| https://www.w3.org/2000/01/rdf-schema#label |
SB-216763
|
| gptkbp:isTarget |
gptkb:glycogen_synthase_kinase-3
|
| gptkbp:IUPACName |
3-(2,4-dichlorophenyl)-4-(1-methyl-1H-imidazol-2-yl)-1H-pyrrole-2,5-dione
|
| gptkbp:molecularWeight |
417.48 g/mol
|
| gptkbp:PubChem_CID |
5311293
|
| gptkbp:synonym |
gptkb:GSK-3β_inhibitor_SB-216763
gptkb:SB216763 |
| gptkbp:usedFor |
diabetes research
neurodegenerative disease research studying Wnt signaling pathway |
| gptkbp:usedIn |
biological research
|
| gptkbp:bfsParent |
gptkb:GSK3B
gptkb:GSK3 |
| gptkbp:bfsLayer |
6
|